JP2001509679A5 - - Google Patents

Download PDF

Info

Publication number
JP2001509679A5
JP2001509679A5 JP1998534602A JP53460298A JP2001509679A5 JP 2001509679 A5 JP2001509679 A5 JP 2001509679A5 JP 1998534602 A JP1998534602 A JP 1998534602A JP 53460298 A JP53460298 A JP 53460298A JP 2001509679 A5 JP2001509679 A5 JP 2001509679A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998534602A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001509679A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/000959 external-priority patent/WO1998031799A2/en
Publication of JP2001509679A publication Critical patent/JP2001509679A/ja
Publication of JP2001509679A5 publication Critical patent/JP2001509679A5/ja
Withdrawn legal-status Critical Current

Links

JP53460298A 1997-01-21 1998-01-21 レセプターをコードするポリヌクレオチドとポリペプチド Withdrawn JP2001509679A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3420497P 1997-01-21 1997-01-21
US3420597P 1997-01-21 1997-01-21
US60/034,205 1997-01-21
US60/034,204 1997-01-21
PCT/US1998/000959 WO1998031799A2 (en) 1997-01-21 1998-01-21 Polynucleotides and polypeptides encoding receptors

Publications (2)

Publication Number Publication Date
JP2001509679A JP2001509679A (ja) 2001-07-24
JP2001509679A5 true JP2001509679A5 (enExample) 2005-09-08

Family

ID=26710688

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53460398A Withdrawn JP2001509029A (ja) 1997-01-21 1998-01-21 ヒトタンパク質
JP53460298A Withdrawn JP2001509679A (ja) 1997-01-21 1998-01-21 レセプターをコードするポリヌクレオチドとポリペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP53460398A Withdrawn JP2001509029A (ja) 1997-01-21 1998-01-21 ヒトタンパク質

Country Status (6)

Country Link
US (8) US6653445B1 (enExample)
EP (2) EP0972022A2 (enExample)
JP (2) JP2001509029A (enExample)
AU (2) AU5923398A (enExample)
CA (2) CA2278248A1 (enExample)
WO (2) WO1998031800A2 (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429646B1 (en) 1995-06-05 2008-09-30 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like 2
US6605699B1 (en) 1997-01-21 2003-08-12 Human Genome Sciences, Inc. Galectin-11 polypeptides
AU5923398A (en) * 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
EP1005546A2 (en) 1997-02-25 2000-06-07 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6146845A (en) * 1997-04-02 2000-11-14 Smithkline Beecham Corporation Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
US6485933B1 (en) 1997-05-07 2002-11-26 Incyte Genomics, Inc. B cell receptor associated proteins
EP0879880A1 (en) * 1997-05-22 1998-11-25 Smithkline Beecham Corporation ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
US5849528A (en) * 1997-08-21 1998-12-15 Incyte Pharmaceuticals, Inc.. Polynucleotides encoding a human S100 protein
CA2218199A1 (en) 1997-12-09 1999-06-09 Mcgill University Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof
EP1095060A4 (en) * 1998-07-06 2006-04-19 Human Genome Sciences GALEKTIN 11
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins
US7071304B2 (en) * 1998-09-01 2006-07-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
NZ510464A (en) * 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof
AU2985200A (en) * 1999-02-03 2000-08-25 Immunex Corporation Novel sialoadhesins
EP1192168A4 (en) * 1999-04-21 2003-04-16 Human Genome Sciences Inc galectin
ATE444971T1 (de) * 1999-06-09 2009-10-15 Genentech Inc Zusammensetzungen und verfahren für die tumor- behandlung
AU2883700A (en) * 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU5619700A (en) * 1999-06-29 2001-01-31 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
US6960651B2 (en) 1999-06-29 2005-11-01 Millennium Pharmaceuticals, Inc. TANGO 332 polypeptides
US6858204B2 (en) 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030125245A1 (en) 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
US6746846B1 (en) 1999-06-30 2004-06-08 Corixa Corporation Methods for diagnosing lung cancer
EP1196565A2 (en) 1999-06-30 2002-04-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6667154B1 (en) * 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6686447B1 (en) 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU5705600A (en) * 1999-06-30 2001-01-22 Takeda Chemical Industries Ltd. Novel polypeptide and dna thereof
US6504010B1 (en) 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6914132B1 (en) 1999-06-30 2005-07-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
NZ521576A (en) 2000-02-29 2005-06-24 Mitsubishi Pharma Corp Novel cyclic amide derivatives
HUP0300997A2 (hu) * 2000-03-23 2003-07-28 Akzo Nobel N.V. A MIA-fehérje alkalmazása immunterápiában
AU2001269865A1 (en) * 2000-06-15 2001-12-24 Biogen, Inc. Novel interferon-induced tetraspan protein and nucleic acids encoding same
WO2002010371A1 (fr) * 2000-08-01 2002-02-07 Kyowa Hakko Kogyo Co., Ltd. Peptide acitf sur le plan physiologique et utilisation de celui-ci
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CN1373218A (zh) * 2001-02-28 2002-10-09 中国医学科学院阜外心血管病医院 炎性抑制因子Fwa116
EP1751187A2 (en) * 2004-05-28 2007-02-14 Idexx Laboratories, Inc. Canine cd20 compositions
US7495073B2 (en) * 2005-03-24 2009-02-24 Asia Hepato Gene Company Short isoform of Annexin A10 at chromosome 4q, termed Annexin 10s (ANXA10s) and methods of use
EP1980571B1 (en) * 2007-04-11 2010-10-13 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
US8372810B2 (en) * 2007-04-11 2013-02-12 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
ES2385115T3 (es) * 2007-04-11 2012-07-18 Gene Signal International Sa Fármaco, medicamento, composición antitumorales y su uso
TWI387750B (zh) * 2009-02-10 2013-03-01 Nat Defense Medical Ct Biomarker and detection method for detecting kidney disease
EP2496604B1 (en) * 2009-11-06 2017-08-23 IDEXX Laboratories, Inc. Canine anti-cd20 antibodies
ES2874306T3 (es) 2010-09-29 2021-11-04 Agensys Inc Conjugados de anticuerpos y fármacos (CAF) que se unen a las proteínas 191P4D12
US20150301068A1 (en) * 2012-01-30 2015-10-22 Vib Vzw Means and method for diagnosis and treatment of alzheimer's disease
EA202191201A1 (ru) 2018-12-03 2022-01-26 Эдженсис, Инк. Фармацевтические композиции, включающие конъюгаты анти-191p4d12 антитело-лекарственное средство, и способы их применения

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3789413T2 (de) * 1986-10-03 1994-07-28 Ciba Geigy Ag Lymphokin-ähnliche Peptide.
US5011912A (en) * 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
FR2636953B1 (fr) 1988-09-26 1990-12-14 Roussy Inst Gustave Nouveaux polypeptides produits par des lymphocytes humains, genes codant pour ces polypeptides et applications pharmaceutiques et biologiques
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
EP0550506B1 (en) 1990-09-05 2002-11-20 The Heart Research Institute Limited Novel chemotactic factor
US5536637A (en) 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
CA2167693C (en) 1993-07-20 2007-01-30 Ulrich Bogdahn Melanoma-inhibiting protein
US5527884A (en) 1993-12-21 1996-06-18 President And Fellows Of Harvard College Mediators of chronic allograft rejection and DNA molecules encoding them
EP0871702B1 (en) 1994-12-06 2005-05-25 Immunex Corporation Cytokine designated lerk-7
WO1997004122A1 (en) * 1995-07-20 1997-02-06 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
AU5923398A (en) * 1997-01-21 1998-08-07 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
US6020478A (en) * 1997-02-28 2000-02-01 Incyte Pharmaceuticals, Inc. Human tumor-associated antigen
US5849528A (en) * 1997-08-21 1998-12-15 Incyte Pharmaceuticals, Inc.. Polynucleotides encoding a human S100 protein
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins

Similar Documents

Publication Publication Date Title
JP2000509637A5 (enExample)
JP2000509635A5 (enExample)
JP2000507042A5 (enExample)
JP2002510447A5 (enExample)
JP2001514650A5 (enExample)
JP2002505002A5 (enExample)
JP2001522265A5 (enExample)
JP2001526635A5 (enExample)
JP2000509587A5 (enExample)
JP2000507369A5 (enExample)
JP2000507433A5 (enExample)
JP2001509029A5 (enExample)
JP2000510793A5 (enExample)
JP2001514678A5 (enExample)
JP2000508022A5 (enExample)
JP2000508841A5 (enExample)
JP2001509336A5 (enExample)
JP2000508680A5 (enExample)
JP2000509853A5 (enExample)
JP2000510969A5 (enExample)
JP2000510247A5 (enExample)
JP2001507464A5 (enExample)
JP2000508836A5 (enExample)
JP2000508102A5 (enExample)
JP2002504857A5 (enExample)